News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Mar 11, 2017 Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview Read Now
Publication Feb 5, 2017 Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn’s disease Read Now
Publication Jan 11, 2017 Review article: dose optimisation of infliximab for acute severe ulcerative colitis Read Now
Publication Jan 10, 2017 Responsiveness of Endoscopic Indices of Disease Activity for Crohn’s Disease Read Now
